Search

See All
Reset

*Schools currently available: Cummings School of Veterinary Medicine, School of Dental Medicine, School of Engineering, The Fletcher School of Law and Diplomacy, Friedman School of Nutrition Science and Policy, School of Medicine, and Graduate School of Biomedical Sciences.

1 - 10 of 176 Results
See All

Conflict of Interest (via CITI)

Online training
https://viceprovost.tufts.edu/research-services/trainings/conflict-interest-citi

Cyclic Peptide Structure Prediction via Structural Ensembles Achieved by Molecular Dynamics and Machine Learning (StrEAMM)

Technology
­Efficient Development of Orally-Bioavailable Cyclic-Peptide Drugs via Molecular Dynamics + Machine Learning BACKGROUND Cyclic peptides are a promising drug modality, combining beneficial traits from
https://viceprovost.tufts.edu/cyclic-peptide-structure-prediction-structural-ensembles-achieved-molecular-dynamics-and-machine

Digital to Analog Converter Circuit

Technology
A Digital-to-Analog Converter based on Resistive Interpolation Load Prof. Sameer Sonkusale at the Electrical and Computer Engineering Department at Tufts has developed a single chip integrated DAC
https://viceprovost.tufts.edu/digital-analog-converter-circuit

Dental Students Safety Orientation

training
https://viceprovost.tufts.edu/research-services/trainings/dental-students-safety-orientation

Introduction to Laser Safety

training
https://viceprovost.tufts.edu/research-services/trainings/introduction-laser-safety

Medical Students Safety Orientation

training
https://viceprovost.tufts.edu/research-services/trainings/medical-students-safety-orientation

New Neisseria gonorrhoeae Vaccine Antigens Expressed During Natural Mucosal Infection

Technology
SUMMARY Researchers at Tufts University discovered novel antigens for a gonococcal vaccine through a unique candidate antigen selection strategy. In vivo, these previously unconsidered protein
https://viceprovost.tufts.edu/new-neisseria-gonorrhoeae-vaccine-antigens-expressed-during-natural-mucosal-infection

Novel IL-38 Analogues are Potent Inhibitors of Neuroinflammatory Mediators

Technology
SUMMARY A Tufts University investigator and their collaborators at R&D Systems Inc., have developed novel IL-38 analogues to treat neuroinflammatory and neurodegenerative diseases like Autism Spectrum
https://viceprovost.tufts.edu/novel-il-38-analogues-are-potent-inhibitors-neuroinflammatory-mediators

Biosafety and Biosecurity Awareness Training for Poliovirus (PPIM)

Online training
https://viceprovost.tufts.edu/research-services/trainings/biosafety-and-biosecurity-awareness-training-poliovirus-ppim

Novel Non-Flushing Niacin Derivatives and Mimetics

Technology
SUMMARY A researcher from the Tufts University School of Medicine has developed novel derivatives of Niacin, which do not produce the uncomfortable side effect of flushing and reddening of the skin
https://viceprovost.tufts.edu/novel-non-flushing-niacin-derivatives-and-mimetics